Biological and Chemical Indicators Market
Market Insights on Biological and Chemical Indicators covering sales outlook, demand forecast & up-to-date key trends
Biological and Chemical Indicators Market By Sterilization Type (Thermal Sterilization, Chemical Sterilization and Radiation Sterilization), Indicator Class (Biological Indicators, Chemical Indicators and Enzyme Indicators) & Region - Forecast 2022 - 2030
Biological and Chemical Indicators Market Snapshot (2022-2030)
[269 Pages] The global biological and chemical indicators market is set to record a market value of US$ 457.8 Mn in the year 2022 with an estimated growth rate of 7.2% CAGR which indicates a positive market growth over the forecast period.
|
Data Points |
Market Insights |
|
Market Value 2022 |
USD 457.8 Mn |
|
Market Value 2030 |
USD 801.4 Mn |
|
CAGR 2022-2030 |
7.2% |
|
Key Players |
The key players are 3M Company, Steris Plc., Getinge AB, Thermo Fisher Scientific Inc., Mesa Labs, Inc., McKesson Medical-Surgical Inc., Crosstex International, Inc. (Cantel Medical Corp.), Propper Manufacturing Co., Inc., Liofilchem S.r.l., Terragene S.A., GKE-GmbH Protak Scientific Ltd., Siltex Australia, Andersen Products, Inc., ParaSure Limited, Excelsior Scientific |
|
Share of Top 5 Countries |
61.4% |
As projected by Future Market Insights, the biological indicators by indicator class are estimated to see a market value of US$ 393.2 Mn, that show more than half of the total biological and chemical indicators market, in the year 2022.
Increasing adoption rate of universal sterilization indicators, increasing advanced product development, rising commercialization of parenteral therapeutics, diagnosing disease, and development of In-house sterilization monitoring solution are the primary factors boosting the development of the biological and chemical indicators market.
Moreover, the number of COVID-19 cases in pandemic creates unmet demand for research based chemical and especially biological indicator. This gave huge growth opportunities for the numerous players in this market.
Biological and chemical indicators market holds nearly 10.4% market value share of the US$ 4.1 Bn sterilization market in 2021. In addition, collaborative efforts and initiatives to do efficient workflow and emerging trend of exploring next-generation techniques is expected to lead to rapid growth in the biological and chemical indicators market.
Let us know your requirement to get
100% FREE customization
How The Market Progressed Till June 2022?
|
Particulars |
Details |
|
H1, 2021 |
7.28% |
|
H1, 2022 Projected |
7.28% |
|
H1, 2022 Outlook |
7.28% |
|
BPS Change - H1, 2022 (O) – H1, 2022 (P) |
(-) 10 ↓ |
|
BPS Change – H1, 2022 (O) – H1, 2021 |
(-) 13 ↓ |
According to FMI, the biological and chemical indicators market will show dip in the BPS change by nearly 13 basis point share (BPS) in H1-2022 (O) on comparison with H1-2021. Furthermore, variation in BPS change is also observed on comparing H1-2022 outlook and H1-2022 projected period by nearly 10 BPS.
The shortcomings of rapid biological indicators include the fact that under unfavorable conditions such as temperature variation, the period available to detect fluorescence is not adequate, thus presenting with low output than expected, and this factor is associated with several disadvantages to the market.
The under developed regions have limitations in-terms of the resources and capabilities for sterilization procedures and monitoring, which contributes to the BPS value reduction.
The growth rates and development possibilities of the global biological and chemical indicators market have been analyzed by FMI. The market is subject to be influence by quality assessment, regulations, and the impact of macro and industrial variables.
The increased volumes of surgery after the advent of the COVID-19 pandemic, as well as the rising rate of hospital acquired infections, are the key driving factors promoting the adoption of biological and chemical indicators.
2015-2021 Biological and Chemical Indicators Market Demand Outlook Compared to 2022-2030 forecast
Rising concern for safety and hygiene, high burden of surgeries and increasing unmet demand due to Covid-19 pandemic are some of the major drivers for biological and chemical indicators market.
Growing risk of infections during surgeries and hospital acquired infections create huge demand for safety and hygiene in sterile production process. Numerous hygiene awareness programs in various regions to promote the use of sterile instruments and equipment’s will create opportunities in the biological and chemical indicators based market in near future.
For Instance, the Georgia Environmental Protection Division (EPD) and U.S. Environmental Protection Agency (EPA) gave joint protocol to provide support by increasing the production at sterilization facilities in the cities of Covington and Madison during COVID-19 as there was high demand and short supply for sterile medical equipment.
Moreover, surgical care is essential to manage diverse health conditions, such as injuries, malignancy, infections and cardiovascular diseases. Increase in the number of surgical procedures will have a direct impact on the sale of biological and chemical indicators. According to a WHO study, in 2020, around 310 million surgical procedures were used to address the burden of different diseases for global population.
Considering this, FMI expects the global biological and chemical indicators market to grow at CAGR of 7.2% through 2030.
Which Factors Are Restraining Demand for Biological and Chemical Indicators?
Inconvenience and long waiting time for results, sub-standard sterilization practices and increasing adoption of disposable biological and chemical indicators are the key factors restraining the market growth over the forecast period.
The classical sterilization indicators such as biological indicators takes longer period of time, about 7 days to show results. In addition, chemical indicators can give false positive results and are generally not recommended by the healthcare regulatory agencies. This disadvantage of classic sterilization indicators are expected to hamper the adoption rate of the products.
In addition, under developed regions have limitations in-terms of the resources and capabilities for sterilization procedures and monitoring. In the non-regulated market, several professionals rely on non-validated sterilization procedures or violate the standard sterilization protocols. Such practices are expected to reduce the use of sterilization indicators during sterilization procedures which is a major factor restraining the market.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystCountry-wise Insights
What Makes the U.S. a Large Market for Biological and chemical indicators?
The U.S. is estimated to account for around 91.1% of the North America biological and chemical indicators market in 2022.
The dominant share of U.S. can mainly be owing to the launch of technologically advanced products, regulatory stringency and compliance and increasing discretionary funding for cancer research in the country. With advancements in manufacturing and digitalization, healthcare professionals expect customized sterilization indicators solutions in the sterilization monitoring operations. Several innovative biological and chemical indicators supplier in the U.S. market are offering customized services of sterilization indicators specific to the need of the end users. This driver is expected to become competitive-edge for the players in the market.
For example, Sterilization Indicators contract manufacturer (OME) and Propper Manufacturing Co., Inc., U.S., offers multiple packaging form and indicators as per customization needs to healthcare end users. These includes cost-effective, environmental friendly and tailored to specific customer needs along with maintaining ISO and FDA compliance.
Additionally, regulatory authorities of regulated markets such as U.S. and ISO regions have issued separate guidelines on the regulatory requirements of the sterilization validation procedures for the compliance of the sterilization procedures. These regulatory stringency is expected to increase the demand of biological and chemical indicators across the global and U.S market.
Why is Germany Considered a Lucrative Biological and chemical indicators Market?
Germany is estimated to account for 17.5% of the Europe biological and chemical indicators market in 2022.
Germany is expected to lead the market owing to technological advancements, rise in incidence of COVID-19 and huge research and development facilities.
German companies have strong focus and continuous investments on research and technological advancement for the development and commercialization of rapid sterilization monitoring products. These are expected to raise the adoption of biological indicators due to their high speed and high efficacy features. This factor drive the demand for the market.
For instance, Protak Scientific Ltd., a Europe-based innovative startup, invented and commercialized the new class of sterilization indicators known as Enzyme Indicators. The product use a thermostable Adenylate kinase (tAK) enzyme isolated from thermophilic bacteria found in hot springs (Sulpholobus acidocaldarius).
What are the Factors Fueling the Demand for Biological and chemical indicators in China?
The biological and chemical indicators market in China is estimated to be worth US$ 32.7 Mn in 2022 in the global market.
Increasing community infections and hospital acquired infections are creating opportunities for biological and chemical indicators in Chinese market.
Biopharmaceutical industry is actively engaged in the development of novel biologics and sensitive products. Among the newly commercialized biologics, majority of therapeutics are formulated in the parenteral dosage form. This increase in parenteral dosage manufacturing volume across the biopharmaceutical industry is expected to fuel the growth of biological and chemical indicators market in china.
How will the Biological and chemical indicators Market Expand across India?
In 2022, the demand for biological and chemical indicators in India is expected to grow at market share of 72.0%. Outsourcing of biopharma research is done extensively in emerging countries like India. Clinical trial partnership of various key players with emerging companies to speed up the clinical trial process is on rise. The partnership is expected to help both companies to explore best results in less time. Such partnership agreement amongst players will help in gaining traction in Indian market.
Category-wise Insights
Demand for Thermal Sterilization continue gaining Traction
By sterilization type, thermal sterilization is anticipated to hold the largest share of 69.4% in 2022. This is due to significant preference to the steam heat sterilization over other sterilization types owing to high possibility of toxicity, handling risk and environmental pollution associated with other sterilization types. Thermal sterilization uses the thermal liability of a microorganism to prevent its growth. Hence a growing popularity and demand for this segment makes it the leading one.
Why Biological Indicators will hold the most of the market share?
By indicator class, biological indicators will lead the market and is projected to account for 85.8% of the total market revenue share in 2022.
Biological indicators segment is widely dominated due to regulatory recommendation to use biological indicators instead of chemical ones to achieve high standard in sterility assurance. In addition, increasing commercialization of user friendly biological indicators with rapid sterilization validation compliance is a key factor in rising biological indicators adoption rate.
Demand for Self-Contained BI continue gaining Traction by form.
By Form, Self-Contained BI is anticipated to hold the largest share of 42.0% in 2022. The high flexibility and efficiency of self-contained BI to deliver rapid results and overall increase in operational efficiency lead this segment to hold the highest share.
Why Biopharma Industry projected maximum growth in the Biological and chemical indicators Market?
By End User, biopharma industry is anticipated to hold nearly half of the global market share in terms of revenue in 2022.
Among all end users, biopharma industry segment is a leading segment which is then followed by hospitals. The rising parenteral formulation including new (biologics/synthetics) and generic formulation and stringent regulatory compliance requirements of sterilization validation is rising the demand of sterilization indicators in biopharmaceuticals industry.
Competitive Landscape
Companies operating in the biological and chemical indicators market are fragmented by nature, with a presence of few players. These players are involved in a number of strategic alliances. The agreement and system automation accelerates the manufacturer’s strategy to capitalize on the market share and capture the significant share of market. Some of the recent instances include:
- In 2020, The Thermo Fisher Scientific, Inc. announced the acquisition of QIAGEN N.V at approximately US$ 11.5 billion.
- In July 2020, 3M company announced Attest Mini Auto-reader 490M, a 24-minute in-house sterilization monitoring solution, the technology designed for the dental professionals use.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
Scope of the Report
|
Attribute |
Details |
|
Forecast Period |
2015-2021 |
|
Historical Data Available for |
2022-2030 |
|
Market Analysis |
USD Million for Value |
|
Key Countries Covered |
US, Canada, Brazil, Mexico, Argentina, Germany, U.K., France, Italy, Spain, Russia, Nordic, China, Japan, South Korea, India, Indonesia, Malaysia, Thailand, Australia, New Zealand, GCC Countries, South Africa, Turkey |
|
Key Segments Covered |
Sterilization Type, Indicator Class, Packaging Form, End User and Region |
|
Key Companies Profiled |
|
|
Report Coverage |
Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
|
Customization & Pricing |
Available upon Request |
Biological and chemical indicators Market by Category
By Sterilization Type
- Thermal Sterilization
- Steam Heat
- Dry Heat
- Chemical Sterilization
- Ethylene Oxide
- Hydrogen Peroxide
- Formaldehyde
- Radiation Sterilization
By Indicator Class
- Biological Indicators
- Geobacillus stearothermophilus (GS) Spores
- Bacillus atrophaeus (BA) Spores
- Others
- Chemical Indicators
- Class 1 (Process)
- Class 4 (Multi-Variable)
- Class 2 (Specific-Use)
- Class 3 (Single-Variable)
- Class 5 (Integrating)
- Class 6 (Cycle Verification)
- Enzyme Indicators
By Packaging Form
- Self-Contained BI
- Spore Suspension BI
- Strip and Disc BI
- Strip and Disc CI
- Others
By End User
- Biopharma Industry
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Diagnostic Labs
- Research Lab
By Region
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle-East & Africa
Frequently Asked Questions
The global biological and chemical indicators market is worth US$ 427.5 Mn in 2021 and is set to expand 1.8X over the forecast years owing to the commercialization of parenteral therapeutics together with the rapid traction in research.
The biological and chemical indicators market is expected to reach US$ 801.4 Mn by the end of 2030 with sales revenue expected to register CAGR of 7.2% over the forecast period.
North America currently holds the largest market share in the biological and chemical indicators and is estimated to hold nearly 40.3% revenue share in 2022 of the global market with U.S. being the leading contributor with a market value of US$ 169.4 Mn in 2022.
Demand of biological and chemical indicators market is expected to register growth in Europe with CAGR of 7.3% over the forecast period.
The biological and chemical indicators in China is likely to observe growth with an impressive growth rate of 6.7% in 2022. The market in China is driven by the growing demand due to rising COVID-19 cases, increasing number of local players and growing technological advancements.
Development of rapid in-house sterilization monitoring solution, customized design and manufacturing fueling the product demand and emergence of new technology (enzyme indicator) for sterilization validation are some of the key trends driving sales of biological and chemical indicators market across the globe.
US, China, Japan, Germany, and U.K., are the top 5 countries that are driving the demand for biological and chemical indicators market.
Leading companies of biological and chemical indicators are 3M Company, Steris Plc., Getinge AB, Thermo Fisher Scientific Inc., Mesa Labs, Inc., McKesson Medical-Surgical Inc., Crosstex International, Inc. (Cantel Medical Corp.), Propper Manufacturing Co., Inc., Liofilchem S.r.l., Terragene S.A., GKE-GmbH, Protak Scientific Ltd., Siltex Australia, Andersen Products, Inc., ParaSure Limited and Excelsior Scientific
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Technology Roadmap
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Market Background
4.1. COVID19 Crisis Analysis
4.1.1. Current COVID19 Statistics and Probable Future Impact
4.1.2. Current GDP Projection and Probable Impact
4.1.3. Current Economic Projection as compared to 2008 Economic analysis
4.1.4. COVID19 and Impact Analysis
4.1.4.1. Revenue By Sterilization Type
4.1.4.2. Revenue By Indicator Class
4.1.4.3. Revenue By Country
4.1.5. 2020 Market Scenario
4.1.6. Quarter by Quarter Forecast
4.1.7. Projected recovery Quarter
4.1.8. Recovery Scenario – Short term, Midterm and Long Term Impact
4.2. Macro-Economic Factors
4.2.1. Global GDP Growth Outlook
4.2.2. Global Healthcare Outlook
4.3. Forecast Factors - Relevance & Impact
4.3.1. Historical Growth of Top Players
4.3.2. Technological Advancement
4.3.3. Adoption of Biological and Chemical Indicators
4.3.4. Cost of Biological and Chemical Indicators
4.3.5. Increasing Epidemic of Infections
4.4. Market Dynamics
4.4.1. Drivers
4.4.2. Restraints
4.4.3. Opportunities
5. Market Context
5.1. Product USPs/ Features
5.2. List of Branded and OEM Products
5.3. Latest Industry Deals/A&M
5.4. Product Adoption / Indicator Class Analysis
5.5. Regulatory Scenario
5.6. Sterilization Process Volume Analysis for Top Countries
6. Global Biological and Chemical Indicators Market Volume (Units) Analysis 2015-2021 and Forecast, 2022-2030
6.1. Historical Market Volume (Units) Analysis, 2015-2021
6.2. Current and Future Market Volume (Units) Projections, 2022-2030
6.2.1. Y-o-Y Growth Trend Analysis
7. Global Biological and Chemical Indicators Market - Pricing Analysis
7.1. Regional Pricing Analysis By Sterilization Type
7.2. Pricing Break-up
7.2.1. Manufacturer Level Pricing
7.2.2. Distributor Level Pricing
7.3. Global Average Pricing Analysis Benchmark
8. Global Biological and Chemical Indicators Market Value (US$ Mn) Analysis 2015-2021 and Forecast, 2022-2030
8.1. Historical Market Value (US$ Mn) Analysis, 2015-2021
8.2. Current and Future Market Value (US$ Mn) Projections, 2022-2030
8.2.1. Y-o-Y Growth Trend Analysis
8.2.2. Opportunity Analysis, 2022-2030
9. Global Biological and Chemical Indicators Market Analysis 2015-2021 and Forecast 2022-2030, By Sterilization Type
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Sterilization Type, 2015–2021
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Sterilization Type, 2022-2030
9.3.1. Thermal Sterilization
9.3.1.1.1. Steam Heat
9.3.1.1.2. Dry Heat
9.3.2. Chemical Sterilization
9.3.2.1.1. Ethylene Oxide
9.3.2.1.2. Hydrogen Peroxide
9.3.2.1.3. Formaldehyde
9.3.3. Radiation Sterilization
9.4. Market Attractiveness Analysis By Sterilization Type
10. Global Biological and Chemical Indicators Market Analysis 2015-2021 and Forecast 2022-2030, By Indicator Class
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By Indicator Class, 2015–2021
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indicator Class, 2022-2030
10.3.1. Biological Indicators
10.3.1.1.1. Bacillus atrophaeus (BA) Spores
10.3.1.1.2. Geobacillus stearothermophilus (GS) Spores
10.3.1.1.3. Others
10.3.2. Chemical Indicators
10.3.2.1.1. Class 1 (Process)
10.3.2.1.2. Class 4 (Multi-Variable)
10.3.2.1.3. Class 2 (Specific-Use)
10.3.2.1.4. Class 3 (Single-Variable)
10.3.2.1.5. Class 5 (Integrating)
10.3.2.1.6. Class 6 (Cycle Verification)
10.3.3. Enzyme Indicators
10.4. Market Attractiveness Analysis By Indicator Class
11. Global Biological and Chemical Indicators Market Analysis 2015-2021 and Forecast 2022-2030, By Packaging Form
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By Packaging Form, 2015–2021
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Packaging Form, 2022-2030
11.3.1. Self-Contained BI
11.3.2. Spore Suspension BI
11.3.3. Strip and Disc BI
11.3.4. Strip and Disc CI
11.3.5. Others
11.4. Market Attractiveness Analysis By End User
12. Global Biological and Chemical Indicators Market Analysis 2015-2021 and Forecast 2022-2030, By End User
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) Analysis By End User, 2015–2021
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022-2030
12.3.1. Biopharma Industry
12.3.2. Hospitals
12.3.3. Clinics
12.3.4. Ambulatory Surgical Centres
12.3.5. Diagnostic Labs
12.3.6. Research Lab
12.4. Market Attractiveness Analysis By End User
13. Global Biological and Chemical Indicators Market Analysis 2015-2021 and Forecast 2022-2030, by Region
13.1. Introduction / Key Findings
13.2. Historical Market Size (US$ Mn) Analysis By Region, 2015–2021
13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2022-2030
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. East Asia
13.3.5. South Asia Pacific
13.3.6. Middle East and Africa (MEA)
13.4. Market Attractiveness Analysis By Region
14. North America Biological and Chemical Indicators Market Analysis 2015-2021 and Forecast 2022-2030
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2021
14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2030
14.3.1. By Country
14.3.1.1. U.S.
14.3.1.2. Canada
14.3.2. By Sterilization Type
14.3.3. By Indicator Class
14.3.4. By Packaging Form
14.3.5. By End User
14.4. Market Attractiveness Analysis
14.5. Key Market Participants - Intensity Mapping
14.6. Drivers and Restraints - Impact Analysis
15. Latin America Biological and Chemical Indicators Market Analysis 2015-2021 and Forecast 2022-2030
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2021
15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2030
15.3.1. By Country
15.3.1.1. Brazil
15.3.1.2. Mexico
15.3.1.3. Argentina
15.3.1.4. Rest of Latin America
15.3.2. By Sterilization Type
15.3.3. By Indicator Class
15.3.4. By Packaging Form
15.3.5. By End User
15.4. Market Attractiveness Analysis
15.5. Key Market Participants - Intensity Mapping
15.6. Drivers and Restraints - Impact Analysis
16. Europe Biological and Chemical Indicators Market Analysis 2015-2021 and Forecast 2022-2030
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2021
16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2030
16.3.1. By Country
16.3.1.1. Germany
16.3.1.2. Italy
16.3.1.3. France
16.3.1.4. U.K.
16.3.1.5. Spain
16.3.1.6. BENELUX
16.3.1.7. Russia
16.3.1.8. Rest of Europe
16.3.2. By Sterilization Type
16.3.3. By Indicator Class
16.3.4. By Packaging Form
16.3.5. By End User
16.4. Market Attractiveness Analysis
16.5. Key Market Participants - Intensity Mapping
16.6. Drivers and Restraints - Impact Analysis
17. South Asia Biological and Chemical Indicators Market Analysis 2015-2021 and Forecast 2022-2030
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2021
17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2030
17.3.1. By Country
17.3.1.1. India
17.3.1.2. Thailand
17.3.1.3. Indonesia
17.3.1.4. Malaysia
17.3.1.5. Rest of South Asia
17.3.2. By Sterilization Type
17.3.3. By Indicator Class
17.3.4. By Packaging Form
17.3.5. By End User
17.4. Market Attractiveness Analysis
17.5. Key Market Participants - Intensity Mapping
17.6. Drivers and Restraints - Impact Analysis
18. East Asia Biological and Chemical Indicators Market Analysis 2015-2021 and Forecast 2022-2030
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2021
18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2030
18.3.1. By Country
18.3.1.1. China
18.3.1.2. Japan
18.3.1.3. South Korea
18.3.2. By Sterilization Type
18.3.3. By Indicator Class
18.3.4. By Packaging Form
18.3.5. By End User
18.4. Market Attractiveness Analysis
18.5. Key Market Participants - Intensity Mapping
18.6. Drivers and Restraints - Impact Analysis
19. Oceania Biological and Chemical Indicators Market Analysis 2015-2021 and Forecast 2022-2030
19.1. Introduction
19.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2021
19.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2030
19.3.1. By Country
19.3.1.1. Australia
19.3.1.2. New Zealand
19.3.2. By Sterilization Type
19.3.3. By Indicator Class
19.3.4. By Packaging Form
19.3.5. By End User
19.4. Market Attractiveness Analysis
19.5. Key Market Participants - Intensity Mapping
19.6. Drivers and Restraints - Impact Analysis
20. Middle East and Africa Biological and Chemical Indicators Market Analysis 2015-2021 and Forecast 2022-2030
20.1. Introduction
20.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2021
20.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2030
20.3.1. By Country
20.3.1.1. GCC Countries
20.3.1.2. Turkey
20.3.1.3. South Africa
20.3.1.4. Rest of Middle East and Africa
20.3.2. By Sterilization Type
20.3.3. By Indicator Class
20.3.4. By Packaging Form
20.3.5. By End User
20.4. Market Attractiveness Analysis
20.5. Key Market Participants - Intensity Mapping
20.6. Drivers and Restraints - Impact Analysis
21. Key and Emerging Countries Biological and Chemical Indicators Market Analysis 2022 & 2030
21.1. Introduction
21.1.1. Market Value Proportion Analysis, By Key Countries
21.1.2. Global Vs. Country Growth Comparison
21.2. U.S. Biological and Chemical Indicators Market Analysis
21.2.1. By Sterilization Type
21.2.2. By Indicator Class
21.2.3. By Packaging Form
21.2.4. By End User
21.3. Canada Biological and Chemical Indicators Market Analysis
21.3.1. By Sterilization Type
21.3.2. By Indicator Class
21.3.3. By Packaging Form
21.3.4. By End User
21.4. Mexico Biological and Chemical Indicators Market Analysis
21.4.1. By Sterilization Type
21.4.2. By Indicator Class
21.4.3. By Packaging Form
21.4.4. By End User
21.5. Brazil Biological and Chemical Indicators Market Analysis
21.5.1. By Sterilization Type
21.5.2. By Indicator Class
21.5.3. By Packaging Form
21.5.4. By End User
21.6. U.K. Biological and Chemical Indicators Market Analysis
21.6.1. By Sterilization Type
21.6.2. By Indicator Class
21.6.3. By Packaging Form
21.6.4. By End User
21.7. Germany Biological and Chemical Indicators Market Analysis
21.7.1. By Sterilization Type
21.7.2. By Indicator Class
21.7.3. By Packaging Form
21.7.4. By End User
21.8. France Biological and Chemical Indicators Market Analysis
21.8.1. By Sterilization Type
21.8.2. By Indicator Class
21.8.3. By Packaging Form
21.8.4. By End User
21.9. Italy Biological and Chemical Indicators Market Analysis
21.9.1. By Sterilization Type
21.9.2. By Indicator Class
21.9.3. By Packaging Form
21.9.4. By End User
21.10. Spain Biological and Chemical Indicators Market Analysis
21.10.1. By Sterilization Type
21.10.2. By Indicator Class
21.10.3. By Packaging Form
21.10.4. By End User
21.11. Russia Biological and Chemical Indicators Market Analysis
21.11.1. By Sterilization Type
21.11.2. By Indicator Class
21.11.3. By Packaging Form
21.11.4. By End User
21.12. China Biological and Chemical Indicators Market Analysis
21.12.1. By Sterilization Type
21.12.2. By Indicator Class
21.12.3. By Packaging Form
21.12.4. By End User
21.13. Japan Biological and Chemical Indicators Market Analysis
21.13.1. By Sterilization Type
21.13.2. By Indicator Class
21.13.3. By Packaging Form
21.13.4. By End User
21.14. South Korea Biological and Chemical Indicators Market Analysis
21.14.1. By Sterilization Type
21.14.2. By Indicator Class
21.14.3. By Packaging Form
21.14.4. By End User
21.15. India Biological and Chemical Indicators Market Analysis
21.15.1. By Sterilization Type
21.15.2. By Indicator Class
21.15.3. By Packaging Form
21.15.4. By End User
21.16. ASEAN Biological and Chemical Indicators Market Analysis
21.16.1. By Sterilization Type
21.16.2. By Indicator Class
21.16.3. By Packaging Form
21.16.4. By End User
21.17. Australia Biological and Chemical Indicators Market Analysis
21.17.1. By Sterilization Type
21.17.2. By Indicator Class
21.17.3. By Packaging Form
21.17.4. By End User
21.18. New Zealand Biological and Chemical Indicators Market Analysis
21.18.1. By Sterilization Type
21.18.2. By Indicator Class
21.18.3. By Packaging Form
21.18.4. By End User
21.19. GCC Countries Biological and Chemical Indicators Market Analysis
21.19.1. By Sterilization Type
21.19.2. By Indicator Class
21.19.3. By Packaging Form
21.19.4. By End User
21.20. Turkey Biological and Chemical Indicators Market Analysis
21.20.1. By Sterilization Type
21.20.2. By Indicator Class
21.20.3. By Packaging Form
21.20.4. By End User
21.21. South Africa Biological and Chemical Indicators Market Analysis
21.21.1. By Sterilization Type
21.21.2. By Indicator Class
21.21.3. By Packaging Form
21.21.4. By End User
22. Market Structure Analysis
22.1. Market Analysis by Tier of Companies
22.2. Market Share Analysis of Top Players
22.3. Market Presence Analysis
22.3.1. Regional Footprint by Players
22.3.2. Product Foot print by Players
22.3.3. Channel Foot Print by Players
23. Competition Analysis
23.1. Competition Dashboard
23.2. Competition Benchmarking
23.3. Competition Deep Dive (Tentative List)
23.3.1. The 3M Company
23.3.1.1. Overview
23.3.1.2. Product Portfolio
23.3.1.3. Profitability by Market Segments (Product/Channel/Region)
23.3.1.4. Sales Footprint
23.3.1.5. Strategy Overview
23.3.1.5.1. Marketing Strategy
23.3.1.5.2. Product Strategy
23.3.1.5.3. Channel Strategy
23.3.2. Steris Plc.
23.3.2.1. Overview
23.3.2.2. Product Portfolio
23.3.2.3. Profitability by Market Segments (Product/Channel/Region)
23.3.2.4. Sales Footprint
23.3.2.5. Strategy Overview
23.3.2.5.1. Marketing Strategy
23.3.2.5.2. Product Strategy
23.3.2.5.3. Channel Strategy
23.3.3. Getinge AB
23.3.3.1. Overview
23.3.3.2. Product Portfolio
23.3.3.3. Profitability by Market Segments (Product/Channel/Region)
23.3.3.4. Sales Footprint
23.3.3.5. Strategy Overview
23.3.3.5.1. Marketing Strategy
23.3.3.5.2. Product Strategy
23.3.3.5.3. Channel Strategy
23.3.4. Crosstex International, Inc.
23.3.4.1. Overview
23.3.4.2. Product Portfolio
23.3.4.3. Profitability by Market Segments (Product/Channel/Region)
23.3.4.4. Sales Footprint
23.3.4.5. Strategy Overview
23.3.4.5.1. Marketing Strategy
23.3.4.5.2. Product Strategy
23.3.4.5.3. Channel Strategy
23.3.5. McKesson Medical-Surgical Inc.
23.3.5.1. Overview
23.3.5.2. Product Portfolio
23.3.5.3. Profitability by Market Segments (Product/Channel/Region)
23.3.5.4. Sales Footprint
23.3.5.5. Strategy Overview
23.3.5.5.1. Marketing Strategy
23.3.5.5.2. Product Strategy
23.3.5.5.3. Channel Strategy
23.3.6. Mesa Labs, Inc
23.3.6.1. Overview
23.3.6.2. Product Portfolio
23.3.6.3. Profitability by Market Segments (Product/Channel/Region)
23.3.6.4. Sales Footprint
23.3.6.5. Strategy Overview
23.3.6.5.1. Marketing Strategy
23.3.6.5.2. Product Strategy
23.3.6.5.3. Channel Strategy
23.3.7. Siltex Australia
23.3.7.1. Overview
23.3.7.2. Product Portfolio
23.3.7.3. Profitability by Market Segments (Product/Channel/Region)
23.3.7.4. Sales Footprint
23.3.7.5. Strategy Overview
23.3.7.5.1. Marketing Strategy
23.3.7.5.2. Product Strategy
23.3.7.5.3. Channel Strategy
23.3.8. Thermo Fisher Scientific
23.3.8.1. Overview
23.3.8.2. Product Portfolio
23.3.8.3. Profitability by Market Segments (Product/Channel/Region)
23.3.8.4. Sales Footprint
23.3.8.5. Strategy Overview
23.3.8.5.1. Marketing Strategy
23.3.8.5.2. Product Strategy
23.3.8.5.3. Channel Strategy
23.3.9. Andersen Products, Inc.
23.3.9.1. Overview
23.3.9.2. Product Portfolio
23.3.9.3. Profitability by Market Segments (Product/Channel/Region)
23.3.9.4. Sales Footprint
23.3.9.5. Strategy Overview
23.3.9.5.1. Marketing Strategy
23.3.9.5.2. Product Strategy
23.3.9.5.3. Channel Strategy
23.3.10. GKE-GmbH
23.3.10.1. Overview
23.3.10.2. Product Portfolio
23.3.10.3. Profitability by Market Segments (Product/Channel/Region)
23.3.10.4. Sales Footprint
23.3.10.5. Strategy Overview
23.3.10.5.1. Marketing Strategy
23.3.10.5.2. Product Strategy
23.3.10.5.3. Channel Strategy
23.3.11. Terragene S.A.
23.3.11.1. Overview
23.3.11.2. Product Portfolio
23.3.11.3. Profitability by Market Segments (Product/Channel/Region)
23.3.11.4. Sales Footprint
23.3.11.5. Strategy Overview
23.3.11.5.1. Marketing Strategy
23.3.11.5.2. Product Strategy
23.3.11.5.3. Channel Strategy
23.3.12. ParaSure Limited
23.3.12.1. Overview
23.3.12.2. Product Portfolio
23.3.12.3. Profitability by Market Segments (Product/Channel/Region)
23.3.12.4. Sales Footprint
23.3.12.5. Strategy Overview
23.3.12.5.1. Marketing Strategy
23.3.12.5.2. Product Strategy
23.3.12.5.3. Channel Strategy
23.3.13. Propper Manufacturing Co., Inc.
23.3.13.1. Overview
23.3.13.2. Product Portfolio
23.3.13.3. Profitability by Market Segments (Product/Channel/Region)
23.3.13.4. Sales Footprint
23.3.13.5. Strategy Overview
23.3.13.5.1. Marketing Strategy
23.3.13.5.2. Product Strategy
23.3.13.5.3. Channel Strategy
23.3.14. Protak Scientific Ltd.
23.3.14.1. Overview
23.3.14.2. Product Portfolio
23.3.14.3. Profitability by Market Segments (Product/Channel/Region)
23.3.14.4. Sales Footprint
23.3.14.5. Strategy Overview
23.3.14.5.1. Marketing Strategy
23.3.14.5.2. Product Strategy
23.3.14.5.3. Channel Strategy
23.3.15. Liofilchem S.r.l.
23.3.15.1. Overview
23.3.15.2. Product Portfolio
23.3.15.3. Profitability by Market Segments (Product/Channel/Region)
23.3.15.4. Sales Footprint
23.3.15.5. Strategy Overview
23.3.15.5.1. Marketing Strategy
23.3.15.5.2. Product Strategy
23.3.15.5.3. Channel Strategy
23.3.16. Excelsior Scientific
23.3.16.1. Overview
23.3.16.2. Product Portfolio
23.3.16.3. Profitability by Market Segments (Product/Channel/Region)
23.3.16.4. Sales Footprint
23.3.16.5. Strategy Overview
23.3.16.5.1. Marketing Strategy
23.3.16.5.2. Product Strategy
23.3.16.5.3. Channel Strategy
24. Assumptions and Acronyms Used
25. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Global Biological and Chemical Indicators Market Volume (‘000 Units) Analysis and Opportunity Assessment 2015–2030, By Sterilization Type
Table 02: Global Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Sterilization Type
Table 03: Global Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indicator Class
Table 04: Global Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Packaging Form
Table 05: Global Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By End User
Table 06: Global Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Region
Table 07: North America Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country
Table 08: North America Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Sterilization Type
Table 09: North America Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indicator Class
Table 10: North America Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Packaging Form
Table 11: North America Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By End User
Table 12: Latin America Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country
Table 13: Latin America Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Sterilization Type
Table 14: Latin America Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indicator Class
Table 15: Latin America Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Packaging Form
Table 16: Latin America Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By End User
Table 17: Europe Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country
Table 18: Europe Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Sterilization Type
Table 19: Europe Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indicator Class
Table 20: Europe Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Packaging Form
Table 21: Europe Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By End User
Table 22: South Asia Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country
Table 23: South Asia Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Sterilization Type
Table 24: South Asia Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indicator Class
Table 25: South Asia Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Packaging Form
Table 26: South Asia Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By End User
Table 27: East Asia Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country
Table 28: East Asia Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Sterilization Type
Table 29: East Asia Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indicator Class
Table 30: East Asia Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Packaging Form
Table 31: East Asia Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By End User
Table 32: Oceania Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country
Table 33: Oceania Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Sterilization Type
Table 34: Oceania Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indicator Class
Table 35: Oceania Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Packaging Form
Table 36: Oceania Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By End User
Table 37: MEA Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country
Table 38: MEA Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Sterilization Type
Table 39: MEA Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indicator Class
Table 40: MEA Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Packaging Form
Table 41: MEA Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By End User
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Global Biological and Chemical Indicators Market Volume (Mn Units) Analysis, 2015-2021
Figure 02: Global Biological and Chemical Indicators Market Volume Forecast (Mn Units), 2022-2030
Figure 03: Global Biological and Chemical Indicators Market Value Analysis (US$ Mn), 2015-2021
Figure 04: Global Biological and Chemical Indicators Market Value Forecast (US$ Mn), 2022-2030
Figure 05: Global Biological and Chemical Indicators Market Absolute $ Opportunity, 2022 - 2030
Figure 06: Global Biological and Chemical Indicators Market Share Analysis (%), By Sterilization Type, 2022-2030
Figure 07: Global Biological and Chemical Indicators Market Y-o-Y Analysis (%), By Sterilization Type, 2022-2030
Figure 08: Global Biological and Chemical Indicators Market Attractiveness Analysis, By Sterilization Type, 2022-2030
Figure 09: Global Biological and Chemical Indicators Market Share Analysis (%), By Indicator Class, 2022-2030
Figure 10: Global Biological and Chemical Indicators Market Y-o-Y Analysis (%), By Indicator Class, 2022-2030
Figure 11: Global Biological and Chemical Indicators Market Attractiveness Analysis by Indicator Class, 2022-2030
Figure 12: Global Biological and Chemical Indicators Market Share Analysis (%), By Packaging Form, 2022-2030
Figure 13: Global Biological and Chemical Indicators Market Y-o-Y Analysis (%), By Packaging Form, 2022-2030
Figure 14: Global Biological and Chemical Indicators Market Attractiveness Analysis by Size, 2022-2030
Figure 15: Global Biological and Chemical Indicators Market Share Analysis (%), By End User, 2022-2030
Figure 16: Global Biological and Chemical Indicators Market Y-o-Y Analysis (%), By End User, 2022-2030
Figure 17: Global Biological and Chemical Indicators Market Attractiveness Analysis by End User, 2022-2030
Figure 18: Global Biological and Chemical Indicators Market Share Analysis (%), By Region, 2022-2030
Figure 19: Global Biological and Chemical Indicators Market Y-o-Y Analysis (%), By Region, 2022-2030
Figure 20: Global Biological and Chemical Indicators Market Attractiveness Analysis by Region, 2022-2030
Figure 21: North America Biological and Chemical Indicators Market Value Share, By Sterilization Type, 2022 (E)
Figure 22: North America Biological and Chemical Indicators Market Value Share, By Indicator Class, 2022 (E)
Figure 23: North America Biological and Chemical Indicators Market Value Share, By Packaging Form, 2022 (E)
Figure 24: North America Biological and Chemical Indicators Market Value Share, By End User, 2022 (E)
Figure 25: North America Biological and Chemical Indicators Market Value Share, By Country, 2022 (E)
Figure 26: North America Biological and Chemical Indicators Market Value Analysis (US$ Mn), 2015-2021
Figure 27: North America Biological and Chemical Indicators Market Value Forecast (US$ Mn), 2022-2030
Figure 28: North America Biological and Chemical Indicators Market Attractiveness Analysis, By Sterilization Type, 2022-2030
Figure 29: North America Biological and Chemical Indicators Market Attractiveness Analysis by Indicator Class, 2022-2030
Figure 30: North America Biological and Chemical Indicators Market Attractiveness Analysis by Packaging Form, 2022-2030
Figure 31: North America Biological and Chemical Indicators Market Attractiveness Analysis by End User, 2022-2030
Figure 32: North America Biological and Chemical Indicators Market Attractiveness Analysis by Country, 2022-2030
Figure 33: Latin America Biological and Chemical Indicators Market Value Share, By Sterilization Type, 2022 (E)
Figure 34: Latin America Biological and Chemical Indicators Market Value Share, By Indicator Class, 2022 (E)
Figure 35: Latin America Biological and Chemical Indicators Market Value Share, By Packaging Form, 2022 (E)
Figure 36: Latin America Biological and Chemical Indicators Market Value Share, By End User, 2022 (E)
Figure 37: Latin America Biological and Chemical Indicators Market Value Share, By Country, 2022 (E)
Figure 38: Latin America Biological and Chemical Indicators Market Value Analysis (US$ Mn), 2015-2021
Figure 39: Latin America Biological and Chemical Indicators Market Value Forecast (US$ Mn), 2022-2030
Figure 40: Latin America Biological and Chemical Indicators Market Attractiveness Analysis, By Sterilization Type, 2022-2030
Figure 41: Latin America Biological and Chemical Indicators Market Attractiveness Analysis by Indicator Class, 2022-2030
Figure 42: Latin America Biological and Chemical Indicators Market Attractiveness Analysis by Packaging Form, 2022-2030
Figure 43: Latin America Biological and Chemical Indicators Market Attractiveness Analysis by End User, 2022-2030
Figure 44: Latin America Biological and Chemical Indicators Market Attractiveness Analysis by Country, 2022-2030
Figure 45: Europe Biological and Chemical Indicators Market Value Share, By Sterilization Type, 2022 (E)
Figure 46: Europe Biological and Chemical Indicators Market Value Share, By Indicator Class, 2022 (E)
Figure 47: Europe Biological and Chemical Indicators Market Value Share, By Packaging Form, 2022 (E)
Figure 48: Europe Biological and Chemical Indicators Market Value Share, By End User, 2022 (E)
Figure 49: Europe Biological and Chemical Indicators Market Value Share, By Country, 2022 (E)
Figure 50: Europe Biological and Chemical Indicators Market Value Analysis (US$ Mn), 2015-2021
Figure 51: Europe Biological and Chemical Indicators Market Value Forecast (US$ Mn), 2022-2030
Figure 52: Europe Biological and Chemical Indicators Market Attractiveness Analysis, By Sterilization Type, 2022-2030
Figure 53: Europe Biological and Chemical Indicators Market Attractiveness Analysis by Indicator Class, 2022-2030
Figure 54: Europe Biological and Chemical Indicators Market Attractiveness Analysis by Packaging Form, 2022-2030
Figure 55: Europe Biological and Chemical Indicators Market Attractiveness Analysis by End User, 2022-2030
Figure 56: Europe Biological and Chemical Indicators Market Attractiveness Analysis by Country, 2022-2030
Figure 57: South Asia Biological and Chemical Indicators Market Value Share, By Sterilization Type, 2022 (E)
Figure 58: South Asia Biological and Chemical Indicators Market Value Share, By Indicator Class, 2022 (E)
Figure 59: South Asia Biological and Chemical Indicators Market Value Share, By Packaging Form, 2022 (E)
Figure 60: South Asia Biological and Chemical Indicators Market Value Share, By End User, 2022 (E)
Figure 61: South Asia Biological and Chemical Indicators Market Value Share, By Country, 2022 (E)
Figure 62: South Asia Biological and Chemical Indicators Market Value Analysis (US$ Mn), 2015-2021
Figure 63: South Asia Biological and Chemical Indicators Market Value Forecast (US$ Mn), 2022-2030
Figure 64: South Asia Biological and Chemical Indicators Market Attractiveness Analysis, By Sterilization Type, 2022-2030
Figure 65: South Asia Biological and Chemical Indicators Market Attractiveness Analysis by Indicator Class, 2022-2030
Figure 66: South Asia Biological and Chemical Indicators Market Attractiveness Analysis by Packaging Form, 2022-2030
Figure 67: South Asia Biological and Chemical Indicators Market Attractiveness Analysis by End User, 2022-2030
Figure 68: South Asia Biological and Chemical Indicators Market Attractiveness Analysis by Country, 2022-2030
Figure 69: East Asia Biological and Chemical Indicators Market Value Share, By Sterilization Type, 2022 (E)
Figure 70: East Asia Biological and Chemical Indicators Market Value Share, By Indicator Class, 2022 (E)
Figure 71: East Asia Biological and Chemical Indicators Market Value Share, By Packaging Form, 2022 (E)
Figure 72: East Asia Biological and Chemical Indicators Market Value Share, By End User, 2022 (E)
Figure 73: East Asia Biological and Chemical Indicators Market Value Share, By Country, 2022 (E)
Figure 74: East Asia Biological and Chemical Indicators Market Value Analysis (US$ Mn), 2015-2021
Figure 75: East Asia Biological and Chemical Indicators Market Value Forecast (US$ Mn), 2022-2030
Figure 76: East Asia Biological and Chemical Indicators Market Attractiveness Analysis, By Sterilization Type, 2022-2030
Figure 77: East Asia Biological and Chemical Indicators Market Attractiveness Analysis by Indicator Class, 2022-2030
Figure 78: East Asia Biological and Chemical Indicators Market Attractiveness Analysis by Packaging Form, 2022-2030
Figure 79: East Asia Biological and Chemical Indicators Market Attractiveness Analysis by End User, 2022-2030
Figure 80: East Asia Biological and Chemical Indicators Market Attractiveness Analysis by Country, 2022-2030
Figure 81: Oceania Biological and Chemical Indicators Market Value Share, By Sterilization Type, 2022 (E)
Figure 82: Oceania Biological and Chemical Indicators Market Value Share, By Indicator Class, 2022 (E)
Figure 83: Oceania Biological and Chemical Indicators Market Value Share, By Packaging Form, 2022 (E)
Figure 84: Oceania Biological and Chemical Indicators Market Value Share, By End User, 2022 (E)
Figure 85: Oceania Biological and Chemical Indicators Market Value Share, By Country, 2022 (E)
Figure 86: Oceania Biological and Chemical Indicators Market Value Analysis (US$ Mn), 2015-2021
Figure 87: Oceania Biological and Chemical Indicators Market Value Forecast (US$ Mn), 2022-2030
Figure 88: Oceania Biological and Chemical Indicators Market Attractiveness Analysis, By Sterilization Type, 2022-2030
Figure 89: Oceania Biological and Chemical Indicators Market Attractiveness Analysis by Indicator Class, 2022-2030
Figure 90: Oceania Biological and Chemical Indicators Market Attractiveness Analysis by Packaging Form, 2022-2030
Figure 91: Oceania Biological and Chemical Indicators Market Attractiveness Analysis by End User, 2022-2030
Figure 92: Oceania Biological and Chemical Indicators Market Attractiveness Analysis by Country, 2022-2030
Figure 93: MEA Biological and Chemical Indicators Market Value Share, By Sterilization Type, 2022 (E)
Figure 94: MEA Biological and Chemical Indicators Market Value Share, By Indicator Class, 2022 (E)
Figure 95: MEA Biological and Chemical Indicators Market Value Share, By Packaging Form, 2022 (E)
Figure 96: MEA Biological and Chemical Indicators Market Value Share, By End User, 2022 (E)
Figure 97: MEA Biological and Chemical Indicators Market Value Share, By Country, 2022 (E)
Figure 98: MEA Biological and Chemical Indicators Market Value Analysis (US$ Mn), 2015-2021
Figure 99: MEA Biological and Chemical Indicators Market Value Forecast (US$ Mn), 2022-2030
Figure 100: MEA Biological and Chemical Indicators Market Attractiveness Analysis, By Sterilization Type, 2022-2030
Figure 101: MEA Biological and Chemical Indicators Market Attractiveness Analysis by Indicator Class, 2022-2030
Figure 102: MEA Biological and Chemical Indicators Market Attractiveness Analysis by Packaging Form, 2022-2030
Figure 103: MEA Biological and Chemical Indicators Market Attractiveness Analysis by End User, 2022-2030
Figure 104: MEA Biological and Chemical Indicators Market Attractiveness Analysis by Country, 2022-2030
Figure 105: U. S. Biological and Chemical Indicators Market Value Share, By Sterilization Type, 2022 (E)
Figure 106: U. S. Biological and Chemical Indicators Market Value Share, By Indicator Class, 2022 (E)
Figure 107: U. S. Biological and Chemical Indicators Market Value Share, By Packaging Form, 2022 (E)
Figure 108: U. S. Biological and Chemical Indicators Market Value Share, By End User, 2022 (E)
Figure 109: U. S. Biological and Chemical Indicators Market Value Analysis (US$ Mn), 2022 & 2030
Figure 110: Canada Biological and Chemical Indicators Market Value Share, By Sterilization Type, 2022 (E)
Figure 111: Canada Biological and Chemical Indicators Market Value Share, By Indicator Class, 2022 (E)
Figure 112: Canada Biological and Chemical Indicators Market Value Share, By Packaging Form, 2022 (E)
Figure 113: Canada Biological and Chemical Indicators Market Value Share, By End User, 2022 (E)
Figure 114: Canada Biological and Chemical Indicators Market Value Analysis (US$ Mn), 2022 & 2030
Figure 115: Brazil Biological and Chemical Indicators Market Value Share, By Sterilization Type, 2022 (E)
Figure 116: Brazil Biological and Chemical Indicators Market Value Share, By Indicator Class, 2022 (E)
Figure 117: Brazil Biological and Chemical Indicators Market Value Share, By Packaging Form, 2022 (E)
Figure 118: Brazil Biological and Chemical Indicators Market Value Share, By End User, 2022 (E)
Figure 119: Brazil Biological and Chemical Indicators Market Value Analysis (US$ Mn), 2022 & 2030
Figure 120: Mexico Biological and Chemical Indicators Market Value Share, By Sterilization Type, 2022 (E)
Figure 121: Mexico Biological and Chemical Indicators Market Value Share, By Indicator Class, 2022 (E)
Figure 122: Mexico Biological and Chemical Indicators Market Value Share, By Packaging Form, 2022 (E)
Figure 123: Mexico Biological and Chemical Indicators Market Value Share, By End User, 2022 (E)
Figure 124: Mexico Biological and Chemical Indicators Market Value Analysis (US$ Mn), 2022 & 2030
Figure 125: U. K. Biological and Chemical Indicators Market Value Share, By Sterilization Type, 2022 (E)
Figure 126: U. K. Biological and Chemical Indicators Market Value Share, By Indicator Class, 2022 (E)
Figure 127: U. K. Biological and Chemical Indicators Market Value Share, By Packaging Form, 2022 (E)
Figure 128: U. K. Biological and Chemical Indicators Market Value Share, By End User, 2022 (E)
Figure 129: U. K. Biological and Chemical Indicators Market Value Analysis (US$ Mn), 2022 & 2030
Figure 130: Germany Biological and Chemical Indicators Market Value Share, By Sterilization Type, 2022 (E)
Figure 131: Germany Biological and Chemical Indicators Market Value Share, By Indicator Class, 2022 (E)
Figure 132: Germany Biological and Chemical Indicators Market Value Share, By Packaging Form, 2022 (E)
Figure 133: Germany Biological and Chemical Indicators Market Value Share, By End User, 2022 (E)
Figure 134: Germany Biological and Chemical Indicators Market Value Analysis (US$ Mn), 2022 & 2030
Figure 135: France Biological and Chemical Indicators Market Value Share, By Sterilization Type, 2022 (E)
Figure 136: France Biological and Chemical Indicators Market Value Share, By Indicator Class, 2022 (E)
Figure 137: France Biological and Chemical Indicators Market Value Share, By Packaging Form, 2022 (E)
Figure 138: France Biological and Chemical Indicators Market Value Share, By End User, 2022 (E)
Figure 139: France Biological and Chemical Indicators Market Value Analysis (US$ Mn), 2022 & 2030
Figure 140: Italy Biological and Chemical Indicators Market Value Share, By Sterilization Type, 2022 (E)
Figure 141: Italy Biological and Chemical Indicators Market Value Share, By Indicator Class, 2022 (E)
Figure 142: Italy Biological and Chemical Indicators Market Value Share, By Packaging Form, 2022 (E)
Figure 143: Italy Biological and Chemical Indicators Market Value Share, By End User, 2022 (E)
Figure 144: Italy Biological and Chemical Indicators Market Value Analysis (US$ Mn), 2022 & 2030
Figure 145: Spain Biological and Chemical Indicators Market Value Share, By Sterilization Type, 2022 (E)
Figure 146: Spain Biological and Chemical Indicators Market Value Share, By Indicator Class, 2022 (E)
Figure 147: Spain Biological and Chemical Indicators Market Value Share, By Packaging Form, 2022 (E)
Figure 148: Spain Biological and Chemical Indicators Market Value Share, By End User, 2022 (E)
Figure 149: Spain Biological and Chemical Indicators Market Value Analysis (US$ Mn), 2022 & 2030
Figure 150: Russia Biological and Chemical Indicators Market Value Share, By Sterilization Type, 2022 (E)
Figure 151: Russia Biological and Chemical Indicators Market Value Share, By Indicator Class, 2022 (E)
Figure 152: Russia Biological and Chemical Indicators Market Value Share, By Packaging Form, 2022 (E)
Figure 153: Russia Biological and Chemical Indicators Market Value Share, By End User, 2022 (E)
Figure 154: Russia Biological and Chemical Indicators Market Value Analysis (US$ Mn), 2022 & 2030
Figure 155: China Biological and Chemical Indicators Market Value Share, By Sterilization Type, 2022 (E)
Figure 156: China Biological and Chemical Indicators Market Value Share, By Indicator Class, 2022 (E)
Figure 157: China Biological and Chemical Indicators Market Value Share, By Packaging Form, 2022 (E)
Figure 158: China Biological and Chemical Indicators Market Value Share, By End User, 2022 (E)
Figure 159: China Biological and Chemical Indicators Market Value Analysis (US$ Mn), 2022 & 2030
Figure 160: Japan Biological and Chemical Indicators Market Value Share, By Sterilization Type, 2022 (E)
Figure 161: Japan Biological and Chemical Indicators Market Value Share, By Indicator Class, 2022 (E)
Figure 162: Japan Biological and Chemical Indicators Market Value Share, By Packaging Form, 2022 (E)
Figure 163: Japan Biological and Chemical Indicators Market Value Share, By End User, 2022 (E)
Figure 164: Japan Biological and Chemical Indicators Market Value Analysis (US$ Mn), 2022 & 2030
Figure 165: South Korea Biological and Chemical Indicators Market Value Share, By Sterilization Type, 2022 (E)
Figure 166: South Korea Biological and Chemical Indicators Market Value Share, By Indicator Class, 2022 (E)
Figure 167: South Korea Biological and Chemical Indicators Market Value Share, By Packaging Form, 2022 (E)
Figure 168: South Korea Biological and Chemical Indicators Market Value Share, By End User, 2022 (E)
Figure 169: South Korea Biological and Chemical Indicators Market Value Analysis (US$ Mn), 2022 & 2030
Figure 170: India Biological and Chemical Indicators Market Value Share, By Sterilization Type, 2022 (E)
Figure 171: India Biological and Chemical Indicators Market Value Share, By Indicator Class, 2022 (E)
Figure 172: India Biological and Chemical Indicators Market Value Share, By Packaging Form, 2022 (E)
Figure 173: India Biological and Chemical Indicators Market Value Share, By End User, 2022 (E)
Figure 174: India Biological and Chemical Indicators Market Value Analysis (US$ Mn), 2022 & 2030
Figure 175: Indonesia Biological and Chemical Indicators Market Value Share, By Sterilization Type, 2022 (E)
Figure 176: Indonesia Biological and Chemical Indicators Market Value Share, By Indicator Class, 2022 (E)
Figure 177: Indonesia Biological and Chemical Indicators Market Value Share, By Packaging Form, 2022 (E)
Figure 178: Indonesia Biological and Chemical Indicators Market Value Share, By End User, 2022 (E)
Figure 179: Indonesia Biological and Chemical Indicators Market Value Analysis (US$ Mn), 2022 & 2030
Figure 180: Australia Biological and Chemical Indicators Market Value Share, By Sterilization Type, 2022 (E)
Figure 181: Australia Biological and Chemical Indicators Market Value Share, By Indicator Class, 2022 (E)
Figure 182: Australia Biological and Chemical Indicators Market Value Share, By Packaging Form, 2022 (E)
Figure 183: Australia Biological and Chemical Indicators Market Value Share, By End User, 2022 (E)
Figure 184: Australia Biological and Chemical Indicators Market Value Analysis (US$ Mn), 2022 & 2030
Figure 185: New Zealand Biological and Chemical Indicators Market Value Share, By Sterilization Type, 2022 (E)
Figure 186: New Zealand Biological and Chemical Indicators Market Value Share, By Indicator Class, 2022 (E)
Figure 187: New Zealand Biological and Chemical Indicators Market Value Share, By Packaging Form, 2022 (E)
Figure 188: New Zealand Biological and Chemical Indicators Market Value Share, By End User, 2022 (E)
Figure 189: New Zealand Biological and Chemical Indicators Market Value Analysis (US$ Mn), 2022 & 2030
Figure 190: GCC Countries Biological and Chemical Indicators Market Value Share, By Sterilization Type, 2022 (E)
Figure 191: GCC Countries Biological and Chemical Indicators Market Value Share, By Indicator Class, 2022 (E)
Figure 192: GCC Countries Biological and Chemical Indicators Market Value Share, By Packaging Form, 2022 (E)
Figure 193: GCC Countries Biological and Chemical Indicators Market Value Share, By End User, 2022 (E)
Figure 194: GCC Countries Biological and Chemical Indicators Market Value Analysis (US$ Mn), 2022 & 2030
Figure 195: Turkey Biological and Chemical Indicators Market Value Share, By Sterilization Type, 2022 (E)
Figure 196: Turkey Biological and Chemical Indicators Market Value Share, By Indicator Class, 2022 (E)
Figure 197: Turkey Biological and Chemical Indicators Market Value Share, By Packaging Form, 2022 (E)
Figure 198: Turkey Biological and Chemical Indicators Market Value Share, By End User, 2022 (E)
Figure 199: Turkey Biological and Chemical Indicators Market Value Analysis (US$ Mn), 2022 & 2030
Figure 200: South Africa Biological and Chemical Indicators Market Value Share, By Sterilization Type, 2022 (E)
Figure 201: South Africa Biological and Chemical Indicators Market Value Share, By Indicator Class, 2022 (E)
Figure 202: South Africa Biological and Chemical Indicators Market Value Share, By Packaging Form, 2022 (E)
Figure 203: South Africa Biological and Chemical Indicators Market Value Share, By End User, 2022 (E)
Figure 204: South Africa Biological and Chemical Indicators Market Value Analysis (US$ Mn), 2022 & 2030
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
